[1]
2011. Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 28, 2 (Dec. 2011), 87–94.